Progressive MS: a new perspective
Unfortunately, DMTs haven’t been as effective in treating progressive MS. In past couple of years, we’ve started to see encouraging results for people with progressive MS, following successful trials of siponimod and ocrelizumab.
But it’s clear that targeting the immune system not is as effective for progressive MS as it has been for relapsing MS.Many of the current DMTs work by targeting a specific type of immune cell, called a T cell. One suggestion is that for progressive MS, instead of focusing on T cells, we should pay more attention to another type of immune cell, called a B cell.
We spoke with Professor Chris Linington from the University of Glasgow about this theory, and his research to provide some answers.
Finding new treatment targets
The more we find out about immune cells, the more complicated their role in MS becomes, particularly with progressive MS.‘We do know that people with progressive MS have immune cells, like B cells, that are active in their brain and spinal cord, so it seems there is something happening with the immune system,’ says Chris. ‘But it doesn’t appear to be the simple case that the immune system is invading the brain as it does in relapsing MS.’
‘We need to learn more about the immune cells that are already present in the brain, and if they’re important we need to develop treatments to target them.’> Find out more about the roles of immune cells in MS
Exploring the mysteries of B cellsB cells usually travel round the blood stream and produce antibody molecules in response to infection. But we now know that B cells and their antibodies also play a very important role in MS.
Chris explains: ‘One of the characteristic features of MS is that these B cells actually enter the brain and sit there. Some of them go in and sit there for years.’One of the key questions that Chris is trying to answer is what the cells (and the molecules they produce) are doing in the brain all this time. It looks like the antibodies are interacting with other cells in the brain and causing more inflammation in the brain and spinal cord.
The hope is, if the researchers can find a way to remove the B cells in the brain, we could slow down or stop MS progression.
The immune system isn’t the only thing causing damage in MS. It looks like the nerves themselves stop working properly, adding to the problem.For some people, mainly those diagnosed with primary progressive MS, this nerve damage may be more important earlier on.
That’s why it’s so important for us to develop treatments that can protect nerves and repair myelin, as well as change the way the immune system behaves. We believe that if we achieve these three goals, we can stop MS in its tracks.
> Watch Chris talk about his work on our YouTube channel - part of our Meet the Researcher video series.A version of this blog first appeared in Research Matters magazine. To receive Research Matters by post please contact email@example.com about subscription. You can also download the full issue for free.
The next research breakthrough is in reach
Your donation will help stop MS.
£30could process one blood sample, giving researchers crucial information about genes and the immune system.
£50could pay for an hour on a microscope, so scientists can study cells and tissue in greater detail and improve their understanding of the biology of MS.
£100could pay for half an hour of MRI use, so researchers can monitor the success of clinical trials and understand MS in more detail.
Every penny you give really does take us a step closer to stopping MS. Your donation will make a difference.
£10a month could pay for lab equipment like microscope slides to study the building blocks of MS
£20a month could pay for lab equipment like petri dishes to grow bacteria important for studying genetics
£30a month could process a blood sample to help us understand what causes MS, so we can stop it in its tracks
Your regular donation means we can keep funding world class MS research with confidence. Together we will stop MS.